Jury Award In 2nd Actos Trial Negated By Decedent's Contributory Negligence

Jury Award In 2nd Actos Trial Negated By Decedent's Contributory Negligence

BALTIMORE - Although a Maryland state court jury found Sept. 26 that Takeda Pharmaceuticals Co. negligently failed to warn a doctor that its Actos diabetes drug can cause bladder cancer, the jury's finding of contributory negligence by the decedent/plaintiff resulted in judgment for the defendant (Diep An v. Takeda Pharmaceuticals America, Inc., No. 24-C12003565, Md. Cir., Baltimore City).

Find full version on lexis Advance®
Access this news story on lexis.com®